A deployment safety case for AI-assisted prostate cancer diagnosis.
Jia Y. et al, (2025), Comput Biol Med, 192
Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial.
Bryant RJ. et al, (2025), Lancet Oncol, 26, 583 - 595
Self-interactive learning: Fusion and evolution of multi-scale histomorphology features for molecular traits prediction in computational pathology.
Hu Y. et al, (2025), Med Image Anal, 101
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis.
Schoenpflug LA. et al, (2024), J Pathol
Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10-year single-centre cohort.
Anbarasan T. et al, (2024), BJUI Compass, 5, 834 - 836
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy.
Hamdy FC. et al, (2024), Eur J Nucl Med Mol Imaging, 51, 3009 - 3025
Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease.
Charlton PV. et al, (2024), Prostate, 84, 977 - 990
Analysis of 3D pathology samples using weakly supervised AI.
Song AH. et al, (2024), Cell, 187, 2502 - 2520.e17
Artificial Intelligence-Based Quality Assessment of Histopathology Whole-Slide Images within a Clinical Workflow: Assessment of 'PathProfiler' in a Diagnostic Pathology Setting.
Browning L. et al, (2024), Diagnostics (Basel), 14
Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.
Hamid MHBA. et al, (2024), Nat Immunol, 25, 834 - 846
Characterising borderline areas in bladder tumour grading with Bayesian graph neural networks
Gao S. et al, (2024), Proceedings - International Symposium on Biomedical Imaging
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.
Figiel S. et al, (2023), Mol Cancer, 22
Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.
Rao SR. et al, (2023), Int J Mol Sci, 24
Department Wide Validation in Digital Pathology-Experience from an Academic Teaching Hospital Using the UK Royal College of Pathologists' Guidance.
Kelleher M. et al, (2023), Diagnostics (Basel), 13
Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique.
Bryant RJ. et al, (2023), BJU Int, 131, 694 - 704